RETRACTED: Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route
Open Access
- 28 June 2020
- journal article
- research article
- Published by MDPI AG in Nanomaterials
- Vol. 10 (7), 1270
- https://doi.org/10.3390/nano10071270
Abstract
Flibanserin (FLB) is a nonhormonal medicine approved by the Food and Drug Administration (FDA) to treat the hypoactive sexual appetite disorder in females. However, the peroral administration of the medicine is greatly affected by its poor bioavailability as a result of its extensive first-pass effect and poor solubility. Aiming at circumventing these drawbacks, this work involves the formulation of optimized FLB transfersome (TRF) loaded intranasal hydrogel. Box–Behnken design was utilized for the improvement of FLB TRFs with decreased size. The FLB-to-phospholipid molar ratio, the edge activator hydrophilic lipophilic balance, and the pH of the hydration medium all exhibited significant effects on the TRF size. The optimized/developed TRFs were unilamellar in shape. Hydroxypropyl methyl cellulose based hydrogel filled with the optimized FLB TRFs exhibited an improved ex vivo permeation when compared with the control FLB-loaded hydrogel. In addition, the optimized TRF-loaded hydrogel exhibited higher bioavailability and enhanced brain delivery relative to the control hydrogel following intranasal administration in Wistar rats. The results foreshadow the possible potential application of the proposed intranasal optimized FLB-TRF-loaded hydrogel to increase the bioavailability and nose-to-brain delivery of the drug.Keywords
Funding Information
- Deanship of Scientific Research (DSR) at King Abdulaziz University, (RG-2–166–41)
This publication has 46 references indexed in Scilit:
- Nanogel-Based PspA Intranasal Vaccine Prevents Invasive Disease and Nasal Colonization by Streptococcus pneumoniaeInfection and Immunity, 2013
- Brain delivery of olanzapine by intranasal administration of transfersomal vesiclesJournal of Liposome Research, 2012
- Sol-Gel Behavior of Hydroxypropyl Methylcellulose (HPMC) in Ionic Media Including Drug ReleaseMaterials, 2011
- Novel sugar esters proniosomes for transdermal delivery of vinpocetine: Preclinical and clinical studiesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2011
- Flibanserin: Initial Evidence of Efficacy on Sexual Dysfunction, in Patients with Major Depressive DisorderThe Journal of Sexual Medicine, 2010
- Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin deliveryInternational Journal of Pharmaceutics, 2010
- ORIGINAL RESEARCH—BASIC SCIENCE: Acute and Repeated Flibanserin Administration in Female Rats Modulates Monoamines Differentially Across Brain Areas: A Microdialysis StudyThe Journal of Sexual Medicine, 2010
- Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers. II. Effect of HPMC with different degrees of methoxy/hydroxypropyl substitutionInternational Journal of Pharmaceutics, 2010
- Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by aids virusesJournal of Drug Targeting, 2009
- Nanogel DDS enables sustained release of IL-12 for tumor immunotherapyBiochemical and Biophysical Research Communications, 2008